Nanxi Chen

机构：Shenyang Pharmaceutical University

发表论文 10 篇 · 总被引 943 次 · h-index 9

代表论文

Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation (2021 · Acta Pharmaceutica Sinica B · 被引 347)
‘Green’ nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases (2021 · Biomaterials · 被引 301)
Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route (2024 · Journal of Nanobiotechnology · 被引 81)
Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues (2020 · Journal of Materials Chemistry B · 被引 62)
Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions (2022 · Expert Opinion on Drug Delivery · 被引 45)
Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization (2024 · Journal of Controlled Release · 被引 44)